跳至主要内容
Permitted list with conditionsBinding ruleASEANOriginal is English已检查官方来源导入

Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5)

Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicyl

ASEAN Annex VI lists this record among preservatives allowed for cosmetic use. Member-state transition rules and deviations still require local verification.

监管决定及完整条件

状态
Permitted list with conditions
法律地位
Binding rule
监管摘要
ASEAN Annex VI lists this record among preservatives allowed for cosmetic use. Member-state transition rules and deviations still require local verification.
条件与限制

0.5% (acid) 0.5% (acid) · Salicylic acid: Not to be used in products for children under three years of age. Not to be used in oral products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Salicylic acid salts: Not to be used in preparations for children under three years of age, except for shampoos · Salicylic acid: Not to be used for children under three years of age (2.1) Salicylic acid salts: Not to be used for children under three years of age (2.2)

物质身份

官方来源名称
Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5)
CAS
69-72-7; 824-35-1; 18917-89-0; 59866-70-5; 54-21-7; 578-36-9; 2174-16-5
EC
200-712-3
身份映射
cas_number
关联成分
SALICYLIC ACID

关联的 CosIng 身份数据

名称和别名

SALICYLIC ACIDsalicylic acidacidum salicylicum

CosIng 描述: Salicylic acid

欧盟清单限制备注: III/98 V/3

已记录的化妆品功能: ANTI-SEBORRHEIC, FRAGRANCE, HAIR CONDITIONING, KERATOLYTIC, PRESERVATIVE, SKIN CONDITIONING

功能页面:ANTI-SEBORRHEIC, FRAGRANCE, HAIR CONDITIONING, KERATOLYTIC, PRESERVATIVE, SKIN CONDITIONING

查看完整的成分档案

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

9 个市场数据集

European Union

Restricted entry found

2 条关联记录 · 2 条含特定条件

打开支持记录

Great Britain

Permitted list with conditionsRestricted

2 条关联记录 · 2 条含特定条件

打开支持记录

New Zealand

Permitted list with conditionsRestricted

8 条关联记录 · 8 条含特定条件

打开支持记录

ASEAN

当前记录
Permitted list with conditionsRestricted

2 条关联记录 · 2 条含特定条件

打开支持记录
CAS 18917-89-0 的 PubChem 二维化学结构
CAS 18917-89-0PubChem CID 54684589

CAS 18917-89-0 的已核实化学信息

(T-4)-Bis(2-(hydroxy-kappaO)benzoato-kappaO)magnesium

Magnesium salicylate is a non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain. It is available in several over-the-counter (OTC) formulations. Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results. — DrugBank

IUPAC 名称
magnesium bis(2-carboxyphenolate)
分子式
C14H10MgO6
分子量
298.53 g/mol
精确质量
298.0327797 Da
单同位素质量
298.0327797 Da
拓扑极性表面积
121.0 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
6
可旋转键
2
重原子
21
共价单元
3

向 PubChem 报告的名称和同义词

Magnesium salicylateMagnesium salicylate anhydrousMagnesium disalicylateBackache reliefJQ69D454N1Backache CapletsBayer Select BackacheBackprin
另有 16 个已报告名称
DoansBack Pain ReliefDoans Extra StrengthDoans Maximum StrengthMedique Back Pain ReliefRefChem:408391Unishield Back Pain ReliefMaximum Strength Backache ReliefMedique at Home Back Pain ReliefBack Pain Relief Extra Strength Doans242-669-3Magnesium Salicylate TetrahydrateMaganmagnesiumsalicylateMobidinmagnesium;2-carboxyphenolate
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2]
InChI
InChI=1S/2C7H6O3.Mg/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
InChIKey
MQHWFIOJQSCFNM-UHFFFAOYSA-L

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 2174-16-5 的 PubChem 二维化学结构
CAS 2174-16-5PubChem CID 25213

CAS 2174-16-5 的已核实化学信息

Trolamine Salicylate

Trolamine salicylate is an organic compound or a salt formed between triethanolamine and salicylic acid. Triethanolamine neutralizes the acidity of the salicylic acid. It is a topical analgesic used for temporary relief of minor pain associated with arthritis, simple backache, muscle strains, sprains, and bruises. Unlike other topical analgesics, trolamine salicylate has no distinct odor which improves patient acceptability. It also displays low systemic absorption upon dermal or topical administration and has low skin irritant properties. As with other salicylates, trolamine salicylate is an inhibitor of cyclo-oxygenase (COX) enzymes with no reported selectivity towards a specific enzyme isoform. Trolamine salicylate serves as an active ingredient in topical over-the-counter products for temporary management of mild to moderate muscular and joint pains. — DrugBank

IUPAC 名称
2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid
分子式
C13H21NO6
分子量
287.31 g/mol
精确质量
287.13688739 Da
单同位素质量
287.13688739 Da
拓扑极性表面积
121.0 Ų
分子复杂度
189.0
形式电荷
0
氢键供体
5
氢键受体
7
可旋转键
7
重原子
20
共价单元
2

向 PubChem 报告的名称和同义词

Triethanolamine salicylateTEA-SalicylateTEA salicylateNeo heliopan tsNeotan wArthricreamH8O4040BHDTrolamine salicylate (USP)
另有 16 个已报告名称
Trolamine salicylate [USP]CannaflexHempvanaArthritis CreamArthritis LeaderArthritis ReliefAsper-FlexAsper-Flex CreamTrolamin SalicylateArthritis with AloeHempvana Pain ReliefArthricream with AloeDCH Arthritis ReliefXCEPTOL PAINCopperlife Pain ReliefCBD Pain Relief Cream
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)O.C(CO)N(CCO)CCO
InChI
InChI=1S/C7H6O3.C6H15NO3/c8-6-4-2-1-3-5(6)7(9)10;8-4-1-7(2-5-9)3-6-10/h1-4,8H,(H,9,10);8-10H,1-6H2
InChIKey
UEVAMYPIMMOEFW-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 54-21-7 的 PubChem 二维化学结构
CAS 54-21-7PubChem CID 16760658

CAS 54-21-7 的已核实化学信息

Sodium Salicylate

Sodium salicylate is an organic molecular entity. — ChEBI

IUPAC 名称
sodium 2-hydroxybenzoate
分子式
C7H5NaO3
分子量
160.10 g/mol
精确质量
160.01363830 Da
单同位素质量
160.01363830 Da
拓扑极性表面积
60.4 Ų
分子复杂度
138.0
形式电荷
0
氢键供体
1
氢键受体
3
可旋转键
1
重原子
11
共价单元
2

向 PubChem 报告的名称和同义词

EnterosalicylKerasalicylAlysineBenzoic acid, 2-hydroxy-, monosodium saltNatrum salicylicumSalicylic acid sodium saltsalicylate sodiumMonosodium 2-hydroxybenzoate
另有 16 个已报告名称
Natrii salicylasWIQ1H85SYPSalicylate, sodiumNSC-202167Benzoic acid, 2-hydroxy-, sodium salt (1:1)Sod salPro-PrinSaliGard 60RefChem:6246UNI-SOLUNI-SOL 60Aspen Sodium Salicylate 48.6%AquaPrime Liquid Sodium SalicylateAquasource Aqua-Prin Water Soluble Sodium Salicylate200-198-0Salsonin
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)[O-])O.[Na+]
InChI
InChI=1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
InChIKey
ABBQHOQBGMUPJH-UHFFFAOYSA-M

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 578-36-9 的 PubChem 二维化学结构
CAS 578-36-9PubChem CID 23664627

CAS 578-36-9 的已核实化学信息

Potassium Salicylate

The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Potassium Salicylate... — Cosmetic Ingredient Review (CIR)

IUPAC 名称
potassium 2-hydroxybenzoate
分子式
C7H5KO3
分子量
176.21 g/mol
精确质量
175.98757550 Da
单同位素质量
175.98757550 Da
拓扑极性表面积
60.4 Ų
分子复杂度
138.0
形式电荷
0
氢键供体
1
氢键受体
3
可旋转键
1
重原子
11
共价单元
2

向 PubChem 报告的名称和同义词

Salicylic acid potassium saltK91YT16P5MUNII-K91YT16P5MBenzoic acid, 2-hydroxy-, monopotassium saltPOTASSIUM SALICYLATE [MI]EINECS 209-421-6Benzoic acid, 2-hydroxy-, potassium salt (1:1)POTASSIUM SALICYLATE [VANDF]
另有 11 个已报告名称
POTASSIUM SALICYLATE [WHO-DD]RefChem:175593POTASSIUM SALICYLATE [INCI]209-421-6potassium,2-hydroxybenzoatepotassium;2-hydroxybenzoateSALICYLIC ACID (POTASSIUM)PotassiumsalicylateAS-15221FT-0632428EN300-20085
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)[O-])O.[K+]
InChI
InChI=1S/C7H6O3.K/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
InChIKey
FRMWBRPWYBNAFB-UHFFFAOYSA-M

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 59866-70-5 的 PubChem 二维化学结构
CAS 59866-70-5PubChem CID 3085170

CAS 59866-70-5 的已核实化学信息

Salicylic acid monoethanolamine

Based on the available information, the CIR Expert Panel concluded that ... MEA-Salicylate... safe as used when formulated to be avoid skin ittiration and when formulated to avoid increasing the skin's sun sensitivity,or, when increased sun sensitivity would be expected, directions for use induce the daily use of sun protection. — Cosmetic Ingredient Review (CIR)

IUPAC 名称
2-aminoethanol;2-hydroxybenzoic acid
分子式
C9H13NO4
分子量
199.20 g/mol
精确质量
199.08445790 Da
单同位素质量
199.08445790 Da
拓扑极性表面积
104.0 Ų
分子复杂度
143.0
形式电荷
0
氢键供体
4
氢键受体
5
可旋转键
2
重原子
14
共价单元
2

向 PubChem 报告的名称和同义词

MEA-SALICYLATEUNII-078ORG4DXO078ORG4DXOEINECS 261-963-2Salicylic acid, compound with 2-aminoethanol (1:1)Monoethanolamine SalicylateSALICYLIC ACID ETHANOLAMINE SALTSALICYLIC ACID, 2-AMINOETHANOL SALT
另有 7 个已报告名称
SALICYLIC ACID MONOETHANOLAMINE [WHO-DD]ETHANOL, 2-AMINO-, 2-HYDROXYBENZOATE (SALT)RefChem:180924MEA-SALICYLATE [INCI]Ethanolamine salicylate [WHO-DD]WGPVWXXJNUNBNB-UHFFFAOYSA-N2-Hydroxybenzoic acid--2-aminoethan-1-ol (1/1)
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)O.C(CO)N
InChI
InChI=1S/C7H6O3.C2H7NO/c8-6-4-2-1-3-5(6)7(9)10;3-1-2-4/h1-4,8H,(H,9,10);4H,1-3H2
InChIKey
WGPVWXXJNUNBNB-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 69-72-7 的 PubChem 二维化学结构
CAS 69-72-7PubChem CID 338

CAS 69-72-7 的已核实化学信息

Salicylic Acid

Salicylic acid is a monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. It has a role as an antiinfective agent, an antifungal agent, a plant hormone, a keratolytic drug, an EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor, a plant metabolite and an algal metabolite. It is a conjugate acid of a salicylate. — ChEBI

IUPAC 名称
2-hydroxybenzoic acid
分子式
C7H6O3
分子量
138.12 g/mol
精确质量
138.031694049 Da
单同位素质量
138.031694049 Da
XLogP3
2.3
拓扑极性表面积
57.5 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
3
可旋转键
1
重原子
10
共价单元
1

向 PubChem 报告的名称和同义词

o-hydroxybenzoic acid2-Carboxyphenolo-CarboxyphenolRetarder WRutranexSalonilKeralytDuoplant
另有 16 个已报告名称
FreezoneSaligelIonilPsoriacid-S-stiftBenzoic acid, 2-hydroxy-Stri-DexSalicylic acid soapVerrugonSalicylic acid collodionPhenol-2-carboxylic acid2-Hydroxybenzenecarboxylic acidTrans-Ver-SalOrthohydroxybenzoic acidAcidum salicylicumAcido salicilicoIonil-Plus
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
1
三维疏水基团
0
三维受体特征
2
三维供体特征
1
三维阴离子中心
1
三维阳离子中心
0
三维构象异构体
3
有效三维可旋转键
1.0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)O
InChI
InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)
InChIKey
YGSDEFSMJLZEOE-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 824-35-1 的 PubChem 二维化学结构
CAS 824-35-1PubChem CID 54684600

CAS 824-35-1 的已核实化学信息

Calcium Salicylate

The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Calcium Salicylate... — Cosmetic Ingredient Review (CIR)

IUPAC 名称
calcium bis(2-carboxyphenolate)
分子式
C14H10CaO6
分子量
314.30 g/mol
精确质量
314.0103289 Da
单同位素质量
314.0103289 Da
拓扑极性表面积
121.0 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
6
可旋转键
2
重原子
21
共价单元
3

向 PubChem 报告的名称和同义词

Calcium disalicylateBenzoic acid, 2-hydroxy-, calcium salt (2:1)0841QCS0DKRefChem:573557212-525-4Calcium 2-hydroxybenzoateUNII-0841QCS0DKEINECS 212-525-4
另有 5 个已报告名称
CALCIUMSALICYLATEcalcium bis(2-hydroxybenzoate)CALCIUM SALICYLATE [II]CALCIUM SALICYLATE [WHO-DD]DB-056609
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Ca+2]
InChI
InChI=1S/2C7H6O3.Ca/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
InChIKey
VBIGULIJWJPALH-UHFFFAOYSA-L

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
ASEAN Cosmetic Directive annexes
来源参考
ASEAN Annex VI, reference 3
来源记录 ID
VI-3
来源版本
2026-1
来源语言
English
翻译状态
Original is English
来源更新
2026-06-22
快照检查时间
2026-08-30 04:44 UTC
验证方法
pdfplumber ruled-table extraction with per-annex reviewed counts
SHA-256
ffad59f6c01a92c82042c54203ee14969425c2a82bd04c2f4012ff82513e69f1

已登记的数据集备注

数据集覆盖范围
Banned, restricted and positive-list substances under the harmonised ASEAN framework
权威性说明
Regional directive; member-state transitions and deviations still require local verification

本记录在市场数据集中的位置

2224
条当前 ASEAN 记录
247
条标记为 Permitted list with conditions 的记录
2224
条来自此来源版本的记录
1930
条带有 CAS 身份的市场记录

状态分布

在 2224 条当前记录中,有 462 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

ASEAN 市场背景

Complete regional annex dataset

覆盖版本: ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026

Annexes II, III, IV, VI and VII covering prohibited, restricted and positive-list substances.

核实清单

  1. Search all ACD annexes by name and identifiers.
  2. Apply product type, maximum level and warning conditions.
  3. Confirm the target member state's adoption and transition date.
  4. Complete the local notification and responsible-company requirements.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Search all ACD annexes by name and identifiers.
  3. Apply product type, maximum level and warning conditions.
  4. Confirm the target member state's adoption and transition date.
  5. Complete the local notification and responsible-company requirements.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC可用
  • 单独的条件文本可用
  • 生效日期未提供
  • 快照哈希与方法可用

本页回答的问题

This identity appears on a market positive list for the list function represented by the source record. Confirm that the intended function and product use fall within the list scope and every stated condition.

Positive-list presence is purpose-specific and is not blanket approval for every cosmetic use. Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.

该记录引用 ASEAN Annex VI, reference 3,来源版本 2026-1。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5). ASEAN Annex VI, reference 3. ASEAN. Source version 2026-1. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/asean/records/4261/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

ASEAN 的解读与局限

This identity appears on a market positive list for the list function represented by the source record.

Confirm that the intended function and product use fall within the list scope and every stated condition.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Permitted list with conditions
  • 法律地位:Binding rule
  • 来源版本:2026-1

它不能证明什么

Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份